Known targets — ChEMBL curated mechanism
GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQ
The experimentally established mechanism targets of Secobarbital. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRB3 known ✓ | P28472 | 1/20 | 0.67 |
| ▸ | GABRA2 known ✓ | P47869 | 1/20 | 0.67 |
| ▸ | GABRB2 known ✓ | P47870 | 1/20 | 0.67 |
| ▸ | MMP9 | P14780 | 1/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.67 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.67 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.67 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.62 |
| ▸ | LMNA | P02545 | 4/20 | 0.54 |
| ▸ | RECQL | P46063 | 1/20 | 0.36 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Secobarbital SCHEMBL41181 | 1.00 | MMP9 (1.00) | MMP9CYP3A4KDM4EALDH1A1GABRB3 | |
| Secobarbital SCHEMBL8085730 | 1.00 | MMP9 (1.00) | MMP9CYP3A4KDM4EALDH1A1GABRB3 | |
| Secobarbital SCHEMBL80734 | 1.00 | MMP9 (1.00) | MMP9CYP3A4KDM4EALDH1A1GABRB3 | |
| Secobarbital SCHEMBL7599361 | 0.98 | MMP9 (0.97) | MMP9CYP3A4KDM4EALDH1A1GABRB3 | |
| Secobarbital SCHEMBL41182 | 0.98 | MMP9 (0.97) | MMP9CYP3A4KDM4EALDH1A1GABRB3 | |
| Secobarbital SCHEMBL614906 | 0.98 | MMP9 (0.97) | MMP9CYP3A4KDM4EALDH1A1GABRB3 | |
| Secobarbital SCHEMBL28198576 | 0.97 | MMP9 (0.94) | MMP9CYP3A4KDM4EALDH1A1GABRB3 | |
| Secobarbital SCHEMBL7778384 | 0.91 | MMP9 (0.83) | MMP9CYP3A4KDM4EALDH1A1GABRB3 | |
| Thiamylal SCHEMBL1666144 | 0.89 | MMP9 (0.79) | MMP9CYP3A4KDM4EALDH1A1GABRB3 | |
| Thiamylal SCHEMBL548050 | 0.89 | MMP9 (0.79) | MMP9CYP3A4KDM4EALDH1A1GABRB3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 11486 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4719552-A1 | INDUCTION OF GENERAL ANESTHESIA IN ADULTS UNDERGOING ELECTIVE SURGERY | Xizang Haisco Pharmaceutical Co., Ltd. (CN) | 2026-04-08 | — | — | EP | claimed |
| US-20260041939-A1 | METHODS FOR THE TREATMENT OF HYPERTENSION VIA TRANSCRANIAL-FOCUSED-ULTRASOUND | SUNNYBROOK RES INST (CA) | 2026-02-12 | — | — | US | claimed |
| EP-3507371-B1 | COMPOSITIONS FOR TREATING DISEASES AND DISORDERS OF THE NERVOUS SYSTEM | UNIV RUTGERS (US) | 2026-01-28 | — | — | EP | claimed |
| EP-4630446-A1 | ENGINEERED SWITCHES FOR IMMUNE CELL ACTIVITY AND METHODS OF USE THEREOF | Dynamic Cell Therapies, Inc. (US) | 2025-10-15 | — | — | EP | claimed |
| EP-4630043-A1 | IMMUNE-ACTIVATING COMPLEXES | Dynamic Cell Therapies, Inc. (US) | 2025-10-15 | — | — | EP | claimed |
| EP-4622640-A1 | COMPOSITIONS AND METHODS FOR MODULATING SLEEP AND USES THEREOF | Brightseed, Inc. (US) | 2025-10-01 | — | — | EP | claimed |
| US-20250295671-A1 | Hazardous Agent Injection System | ANTARES PHARMA, INC. (US) | 2025-09-25 | — | — | US | claimed |
| US-20250281451-A1 | COMPOSITIONS AND METHODS FOR MODULATING SLEEP AND USES THEREOF | BRIGHTSEED, INC. | 2025-09-11 | — | — | US | claimed |
| US-12383743-B2 | Treatment of addiction and dependency | TACA JR ARTURO C (US) | 2025-08-12 | — | — | US | claimed |
| US-20250249002-A1 | PHARMACEUTICAL COMPOSITION FOR TOPICAL WOUND TREATMENT | CONSEJO NACIONAL DE INVESTIGACIONES CIENTIFICAS Y TECN (AR) | 2025-08-07 | — | — | US | claimed |
| US-4557934-A | ALONG WITH A DIOL PYRROLIDONE OR AN AZACYCLOPENTAN-2-ONE | THE PROCTER & GAMBLE COMPANY (US) | 1985-12-10 | — | — | US | claimed |
| US-4466953-A | Polymeric diffusion matrix | KEY PHARMACEUTICALS, INC. (US) | 1984-08-21 | — | — | US | claimed |
| US-4244939-A | RADIOIMMUNOASSAY | BAXTER TRAVENOL LABORATORIES, INC. (US) | 1981-01-13 | — | — | US | claimed |
| US-4175119-A | Composition and method to prevent accidental and intentional overdosage with psychoactive drugs | PORTER GARRY L | 1979-11-20 | — | — | US | claimed |
| US-4168308-A | Composition for enhancing the administration of pharmacologically active agents | APOTEKSVARUCENTRALEN VITRUM AB (SE) | 1979-09-18 | — | — | US | claimed |
| US-4126684-A | 4-AMINO-3-P-HALOPHENYLBUTYRIC ACIDS AND THEIR DERIVATIVES USED IN THE CONTROL OF NARCOTIC ABUSE | CIBA-GEIGY CORPORATION (US) | 1978-11-21 | — | — | US | claimed |
| US-4107153-A | Heat-resistant thermosetting polyimide resin | TOSHIBA CHEMICAL PRODUCTS CO., LTD. (JP) | 1978-08-15 | — | — | US | claimed |
| US-4097545-A | Heat-resistant thermosetting polyimide resin with bis-phenol-epichlorohydrin reaction product | TOSHIBA CHEMICAL PRODUCTS CO. LTD. (JA) | 1978-06-27 | — | — | US | claimed |
| US-4036823-A | Barbituric acid antigenic conjugates, their preparation, antibodies and use | BIOLOGICAL DEVELOPMENTS, INC. (US) | 1977-07-19 | — | — | US | claimed |
| US-3952091-A | Simultaneous multiple radioimmunoassay | HOFFMANN-LA ROCHE INC. (US) | 1976-04-20 | — | — | US | claimed |